S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Can A.I. Launch You into Your Next Trading Frontier? (Ad)pixel
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Can A.I. Launch You into Your Next Trading Frontier? (Ad)pixel
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Can A.I. Launch You into Your Next Trading Frontier? (Ad)pixel
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Can A.I. Launch You into Your Next Trading Frontier? (Ad)pixel
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
NASDAQ:CDLX

Cardlytics - CDLX Stock Forecast, Price & News

$10.06
+0.50 (+5.23%)
(As of 10/4/2022 12:00 AM ET)
Add
Compare
Today's Range
$9.76
$10.36
50-Day Range
$9.32
$17.38
52-Week Range
$8.68
$97.21
Volume
395,689 shs
Average Volume
524,472 shs
Market Capitalization
$330.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.20

Cardlytics MarketRank™ Forecast

Analyst Rating
Hold
1.80 Rating Score
Upside/​Downside
100.8% Upside
$20.20 Price Target
Short Interest
Healthy
13.74% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
1.10mentions of Cardlytics in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$263,736 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.25) to ($2.73) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.37 out of 5 stars

Business Services Sector

129th out of 336 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

22nd out of 67 stocks

CDLX stock logo

About Cardlytics (NASDAQ:CDLX) Stock

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

CDLX Stock News Headlines

Cardlytics, Inc. (NASDAQ: CDLX)
What 7 Analyst Ratings Have To Say About Cardlytics
Cardlytics: Q2 Earnings Snapshot - Greenwich Time
See More Headlines
Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

CDLX Company Calendar

Last Earnings
8/02/2022
Today
10/05/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Current Symbol
NASDAQ:CDLX
Fax
N/A
Employees
591
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$20.20
High Stock Price Forecast
$35.00
Low Stock Price Forecast
$13.00
Forecasted Upside/Downside
+100.8%
Consensus Rating
Hold
Rating Score (0-4)
1.80
Research Coverage
5 Analysts

Profitability

Net Income
$-128,570,000.00
Pretax Margin
-53.26%

Debt

Sales & Book Value

Annual Sales
$267.12 million
Book Value
$20.76 per share

Miscellaneous

Free Float
31,677,000
Market Cap
$330.91 million
Optionable
Not Optionable
Beta
2.15

Key Executives

  • Mr. Scott D. GrimesMr. Scott D. Grimes (Age 59)
    Co-Founder & Exec. Chairman
    Comp: $3.31M
  • Ms. Lynne Marie LaubeMs. Lynne Marie Laube (Age 52)
    Co-Founder, CEO & Director
    Comp: $727.13k
  • Mr. Andrew C. ChristiansenMr. Andrew C. Christiansen (Age 43)
    Chief Financial Officer
    Comp: $540.28k
  • Mr. Kirk L. Somers Esq. (Age 57)
    Sec.
    Comp: $512.61k
  • Mr. Peter Chan
    Chief Technology Officer
  • Mr. Peter Gleason (Age 53)
    Chief Admin. Officer
  • Mr. Nick Lynton
    Chief Legal & Privacy Officer
  • Angie Amberg
    Head of Brand Marketing & Communications
  • Mr. Peter Davies
    Head of Sales Strategy & Operations
  • Mr. Craig Snodgrass (Age 49)
    Chief Data Officer













CDLX Stock - Frequently Asked Questions

Should I buy or sell Cardlytics stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CDLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDLX, but not buy additional shares or sell existing shares.
View CDLX analyst ratings
or view top-rated stocks.

What is Cardlytics' stock price forecast for 2022?

5 Wall Street research analysts have issued 1-year target prices for Cardlytics' stock. Their CDLX share price forecasts range from $13.00 to $35.00. On average, they anticipate the company's share price to reach $20.20 in the next twelve months. This suggests a possible upside of 100.8% from the stock's current price.
View analysts price targets for CDLX
or view top-rated stocks among Wall Street analysts.

How have CDLX shares performed in 2022?

Cardlytics' stock was trading at $66.09 at the beginning of the year. Since then, CDLX stock has decreased by 84.8% and is now trading at $10.06.
View the best growth stocks for 2022 here
.

When is Cardlytics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our CDLX earnings forecast
.

How were Cardlytics' earnings last quarter?

Cardlytics, Inc. (NASDAQ:CDLX) announced its earnings results on Tuesday, August, 2nd. The company reported ($0.95) earnings per share for the quarter, hitting the consensus estimate of ($0.95). The business earned $75.41 million during the quarter, compared to analyst estimates of $76.62 million. Cardlytics had a negative net margin of 50.15% and a negative trailing twelve-month return on equity of 15.46%.

What guidance has Cardlytics issued on next quarter's earnings?

Cardlytics updated its second quarter 2022 earnings guidance on Wednesday, August, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $74.50 million-$76.50 million, compared to the consensus revenue estimate of $76.99 million.

What is Lynne Laube's approval rating as Cardlytics' CEO?

26 employees have rated Cardlytics Chief Executive Officer Lynne Laube on Glassdoor.com. Lynne Laube has an approval rating of 86% among the company's employees. 61.0% of employees surveyed would recommend working at Cardlytics to a friend.

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Block (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS), Alibaba Group (BABA), Trade Desk (TTD), QUALCOMM (QCOM) and Twilio (TWLO).

When did Cardlytics IPO?

(CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

What is Cardlytics' stock symbol?

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

How do I buy shares of Cardlytics?

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardlytics' stock price today?

One share of CDLX stock can currently be purchased for approximately $10.06.

How much money does Cardlytics make?

Cardlytics (NASDAQ:CDLX) has a market capitalization of $330.91 million and generates $267.12 million in revenue each year. The company earns $-128,570,000.00 in net income (profit) each year or ($4.56) on an earnings per share basis.

How many employees does Cardlytics have?

The company employs 591 workers across the globe.

How can I contact Cardlytics?

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The official website for the company is www.cardlytics.com. The company can be reached via phone at (888) 798-5802 or via email at ir@cardlytics.com.

This page (NASDAQ:CDLX) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.